FI952985A - Kuumeenhoito- ja puudutusmenetelmiä ja optisesti puhdasta R-ketorolakkia sisältäviä koostumuksia - Google Patents

Kuumeenhoito- ja puudutusmenetelmiä ja optisesti puhdasta R-ketorolakkia sisältäviä koostumuksia Download PDF

Info

Publication number
FI952985A
FI952985A FI952985A FI952985A FI952985A FI 952985 A FI952985 A FI 952985A FI 952985 A FI952985 A FI 952985A FI 952985 A FI952985 A FI 952985A FI 952985 A FI952985 A FI 952985A
Authority
FI
Finland
Prior art keywords
ketorolac
pain
optically pure
anesthesia
compositions containing
Prior art date
Application number
FI952985A
Other languages
English (en)
Swedish (sv)
Other versions
FI952985A0 (fi
Inventor
Timothy J Barberich
Stephen L Matson
William J Wechter
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of FI952985A0 publication Critical patent/FI952985A0/fi
Publication of FI952985A publication Critical patent/FI952985A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI952985A 1992-12-17 1995-06-16 Kuumeenhoito- ja puudutusmenetelmiä ja optisesti puhdasta R-ketorolakkia sisältäviä koostumuksia FI952985A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99198192A 1992-12-17 1992-12-17
PCT/US1993/012299 WO1994013283A1 (en) 1992-12-17 1993-12-17 Antipyretic and analgesic methods and compositions containing optically pure r-ketorolac

Publications (2)

Publication Number Publication Date
FI952985A0 FI952985A0 (fi) 1995-06-16
FI952985A true FI952985A (fi) 1995-08-16

Family

ID=25537797

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952985A FI952985A (fi) 1992-12-17 1995-06-16 Kuumeenhoito- ja puudutusmenetelmiä ja optisesti puhdasta R-ketorolakkia sisältäviä koostumuksia

Country Status (14)

Country Link
US (1) US5382591A (fi)
EP (1) EP0674511B1 (fi)
JP (1) JP2957701B2 (fi)
KR (1) KR100264814B1 (fi)
AT (1) ATE150969T1 (fi)
AU (1) AU696620B2 (fi)
CA (1) CA2151724C (fi)
DE (1) DE69309492T2 (fi)
DK (1) DK0674511T3 (fi)
ES (1) ES2100046T3 (fi)
FI (1) FI952985A (fi)
GR (1) GR3023741T3 (fi)
NO (1) NO307546B1 (fi)
WO (1) WO1994013283A1 (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464609A (en) * 1990-03-16 1995-11-07 The Procter & Gamble Company Use of ketorolac for treatment of oral diseases and conditions
US5382591A (en) * 1992-12-17 1995-01-17 Sepracor Inc. Antipyretic and analgesic methods using optically pure R-ketorolac
US6160018A (en) * 1995-03-13 2000-12-12 Loma Linda University Medical Center Prophylactic composition and method for alzheimer's Disease
US5981592A (en) * 1995-03-13 1999-11-09 Loma Linda University Medical Center Method and composition for treating cystic fibrosis
US5955504A (en) * 1995-03-13 1999-09-21 Loma Linda University Medical Center Colorectal chemoprotective composition and method of preventing colorectal cancer
EP1642575B1 (en) * 1997-03-10 2009-10-28 Loma Linda University Medical Center Use of r-carprofen for the prevention of alzheimer's disease
US6451806B2 (en) 1999-09-29 2002-09-17 Adolor Corporation Methods and compositions involving opioids and antagonists thereof
US6576191B1 (en) * 1999-09-30 2003-06-10 Therox, Inc. Apparatus for blood oxygenation
US6469030B2 (en) 1999-11-29 2002-10-22 Adolor Corporation Methods for the treatment and prevention of ileus
CA2406383A1 (en) * 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research A.beta.42 lowering agents
US20030027867A1 (en) * 2001-06-29 2003-02-06 Myriad Genetics, Incorporated Use of R-NSAID compounds for anti-HIV treatment
US20030181426A1 (en) * 2002-02-11 2003-09-25 Eisenach James C. Compositions and methods for treating pain using cyclooxygenase-1 inhibitors
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS
US20050042284A1 (en) * 2003-07-11 2005-02-24 Myriad Genetics, Incorporated Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
PL1654002T5 (pl) 2003-08-07 2014-06-30 Allergan Inc Kompozycje do dostarczania środków terapeutycznych do oczu
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
CN1946906A (zh) * 2004-04-29 2007-04-11 吉斯通护岸系统股份有限公司 用于墙、护墙和类似物的饰面
CA2618985A1 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CA2615063A1 (en) * 2005-07-22 2007-02-01 Myriad Genetics, Inc. High drug load formulations and dosage forms
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
US9192571B2 (en) * 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
US7842714B2 (en) * 2008-03-03 2010-11-30 Allergan, Inc. Ketorolac tromethamine compositions for treating ocular pain
MX2008003230A (es) * 2008-03-07 2009-09-07 Senosiain S A De C V Lab Composicion famaceutica oral que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b.
CN112094271B (zh) * 2019-06-18 2023-03-21 鲁南制药集团股份有限公司 一种酮咯酸晶型及其制备方法
CN110540542A (zh) * 2019-09-12 2019-12-06 南京海融制药有限公司 一种苯乙酸类化合物的钠盐、结晶形式及其制备方法
EP4110329A4 (en) * 2020-02-24 2024-04-10 Yinuoke Medicine Science Technology Company Ltd. COMPOSITIONS AND METHODS FOR TREATING CYTOKINE STORM AND CYTOKINE RELEASE SYNDROME
CN114276350B (zh) * 2020-09-28 2023-05-16 鲁南制药集团股份有限公司 一种酮咯酸与吩嗪共晶及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4089969A (en) * 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
KR880701287A (ko) * 1986-04-16 1988-07-26 원본미기재 광학적으로 활성인 1,2-디하이드로-3H-피롤로(1, 2a)피롤-1-카복실산 유도체의 제조방법
ES2086536T3 (es) * 1990-03-16 1996-07-01 Procter & Gamble Uso de ketorolaco para el tratamiento de la enfermedad periodontal.
JP3541849B2 (ja) * 1991-04-19 2004-07-14 久光製薬株式会社 消炎鎮痛貼付剤
US5382591A (en) * 1992-12-17 1995-01-17 Sepracor Inc. Antipyretic and analgesic methods using optically pure R-ketorolac

Also Published As

Publication number Publication date
AU696620B2 (en) 1998-09-17
ES2100046T3 (es) 1997-06-01
CA2151724C (en) 2000-10-31
NO952418D0 (no) 1995-06-16
WO1994013283A1 (en) 1994-06-23
CA2151724A1 (en) 1994-06-23
KR950703951A (ko) 1995-11-17
JP2957701B2 (ja) 1999-10-06
DK0674511T3 (da) 1997-04-21
JPH08505133A (ja) 1996-06-04
DE69309492T2 (de) 1997-07-10
US5382591A (en) 1995-01-17
KR100264814B1 (ko) 2000-09-01
EP0674511B1 (en) 1997-04-02
NO307546B1 (no) 2000-04-25
GR3023741T3 (en) 1997-09-30
ATE150969T1 (de) 1997-04-15
NO952418L (no) 1995-08-03
EP0674511A1 (en) 1995-10-04
DE69309492D1 (de) 1997-05-07
FI952985A0 (fi) 1995-06-16
AU5872194A (en) 1994-07-04

Similar Documents

Publication Publication Date Title
FI952985A (fi) Kuumeenhoito- ja puudutusmenetelmiä ja optisesti puhdasta R-ketorolakkia sisältäviä koostumuksia
EP0727994A4 (en) ANTIPYRETIC AND ANALGESIC METHODS AND COMPOSITIONS CONTAINING OPTICALLY PURE ETODOLIC ACID
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
RU94042899A (ru) Способ достижения болеутоляющего эффекта, способ лечения и профилактики гипертермии у человека, болеутоляющая и жаропонижающая композиции, содержащие оптически чистый r (-) кетопрофен
ATE113834T1 (de) Zusammensetzung zur behandlung der schizophrenie.
DK1137416T3 (da) Anvendelse af langkædede N-alkylderivater af deoxynojirimycin til fremstilling af et lægemiddel til behandling af glycolipidophobnings-sygdomme
EE03148B1 (et) Kristallilise magneesiumomeprasooli ravimvorm, selle valmistamise protsess ja kasutamine
DE69213814D1 (de) Melatoninderivate zur Behandlung von Schlafstörungen und zur Pre-Anästhesie
EP1022025A3 (en) Method and compositions for treating emesis nausea and other disorders using optically pure R(+) ondansetron
DE69400799D1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
ATE189601T1 (de) Verwendung von raloxifen und dessen analogen zur herstellung eines medikaments zur behandlung viraler erkrankungen
ES555118A0 (es) Metodo de preparar medicamentos que incluyen un agente buscador de hueso y un inhibidor de anhidrasa carbonica, para impedir y curar enfermedades oseas.
DE3850154D1 (de) Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression.
DK0769945T3 (da) Brug af 2-phenyl-3-aroylbenzothiophenderivater til fremstilling af et medikament til behandling af knogler og knoglebrud
PT98764A (pt) Processo para a preparacao de composicoes contendo factor de desenvolvimento de insulina 1 completo para o tratamento terapeutico ou profilactico de estado catabolicos
DK0704219T3 (da) Anvendelse af faktor for osteoblastisk celledeling
DK0453337T3 (da) Anvendelse af hexetidin eller derivater eller salte deraf til fremstilling af et farmaceutisk præparat til oftalmologisk anvendelse
ATE136776T1 (de) Verwendung von heptastigmin zur behandlung der zerebralen ictus